Pairing GOx With a Potent H 2 O 2 ‐consuming Co‐Cu x O Nanozyme for Starvation/Cuproptosis/Chemodynamic Synergistic Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Junzhen Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Hydrogen Peroxide, Glucose Oxidase, Copper, Cuproptosis. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Heilongjiang Postdoctoral Science Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Combining glucose oxidase (GOx) with peroxidase‐like (POD) nanozymes is a well‐established strategy for synergistic starvation and chemodynamic therapy (CDT). However, the low catalytic efficacy of most nanozymes compared to GOx often leads to wasteful accumulation of hydrogen peroxide (H 2 O 2 ), which can inhibit GOx activity and limit the therapeutic effect. Therefore, enhancing the H 2 O 2 consumption efficiency is critical to unlocking the full potential of this approach. Here, we designed a cobalt‐doped mixed‐valence copper oxide (Co‐Cu x O) nanozyme with metals uniformly dispersed using a polyacrylic acid (PAA) scaffolding method. This nanozyme tightly couples the redox cycles that drive the valence state interconversions of cobalt (Co) and copper (Cu) elements, enabling highly efficient consumption of H 2 O 2 and glutathione (GSH). While Co provides multi‐valent characteristics ideal for Fenton‐like reactions, Cu acts not only as a co‐catalyst but also triggers cuproptosis. We further installed GOx onto the nanozyme surface, allowing H 2 O 2 produced by GOx channels to Co‐Cu x O active sites, thereby further accelerating the catalytic cascade. In vitro experiments demonstrated effective glucose and H 2 O 2 depletion with abundant hydroxyl radical (·OH) generation. When functionalized with hyaluronic acid (HA) for tumor targeting, in vivo experiments demonstrated robust multimodal cell death, confirming the high efficacy of our integrated dual‐enzyme platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, Harbin Medical University, Harbin, China.
- Research Center for Pharmacoinformatic, College of Pharmacy, Harbin Medical University, Harbin, China.
ORCID-Profile: Jingling Tang, Manjie Zhang, Bin Sun
Förderung
- Heilongjiang Postdoctoral Science Foundation
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, J., Wang, H., Zhang, Q., Ao, G., Yang, S., Gao, W., Du, H., Zhang, F., Han, M., Yu, X., Zhang, Y., Tang, J., Zhang, M., & Sun, B. (2026). Pairing GOx With a Potent H 2 O 2 ‐consuming Co‐Cu x O Nanozyme for Starvation/Cuproptosis/Chemodynamic Synergistic Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71708
Vancouver
Wang J, Wang H, Zhang Q, Ao G, Yang S, Gao W, et al. Pairing GOx With a Potent H 2 O 2 ‐consuming Co‐Cu x O Nanozyme for Starvation/Cuproptosis/Chemodynamic Synergistic Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71708
BibTeX
@article{Wang2026,
author = {Wang, Junzhen and Wang, Hao and Zhang, Qian and Ao, Guofeng and Yang, Shiya and Gao, Wei and Du, Haoyang and Zhang, Fujuan and Han, Mengying and Yu, Xinyuan and Zhang, Yu and Tang, Jingling and Zhang, Manjie and Sun, Bin},
title = {Pairing GOx With a Potent H 2 O 2 ‐consuming Co‐Cu x O Nanozyme for Starvation/Cuproptosis/Chemodynamic Synergistic Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71708}
}
EUVIMED